title: Therapeutic effect of thalidomide through cytokine and chemokine regulation in herpes simplex virus-induced Behçet's disease-like animal model.
authors.affiliation: Laboratory of Cell Biology, Ajou University Institute for Medical Sciences, Suwon, Korea.
authors.forename: Seonghyang
authors.initials: S
authors.lastname: Sohn
authors.forename: Eun-So
authors.initials: ES
authors.lastname: Lee
authors.forename: Seung Ihm
authors.initials: SI
authors.lastname: Lee
authors.forename: Young Ae
authors.initials: YA
authors.lastname: Kim
authors.forename: Hyuk Jae
authors.initials: HJ
authors.lastname: Kwon
authors.forename: Dongsik
authors.initials: D
authors.lastname: Bang
authors.forename: Sungnack
authors.initials: S
authors.lastname: Lee
mesh_terms: D000818:Animals; D001528:Behcet Syndrome / Q000188:drug therapy* / Q000276:immunology* / Q000821:virology; D054407:Chemokine CCL4; D018925:Chemokines / Q000276:immunology*; D016207:Cytokines / Q000187:drug effects / Q000276:immunology*; D004195:Disease Models, Animal; D005786:Gene Expression Regulation / Q000187:drug effects; D006561:Herpes Simplex / Q000150:complications*; D019402:Macrophage Inflammatory Proteins / Q000235:genetics; D008297:Male; D008562:Membrane Glycoproteins / Q000235:genetics; D051379:Mice; D008813:Mice, Inbred ICR; D054353:Perforin; D052899:Pore Forming Cytotoxic Proteins; D012333:RNA, Messenger / Q000235:genetics; D013792:Thalidomide / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics
chemical_list: D054407:Chemokine CCL4; D018925:Chemokines; D016207:Cytokines; D019402:Macrophage Inflammatory Proteins; D008562:Membrane Glycoproteins; D052899:Pore Forming Cytotoxic Proteins; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; D054353:Perforin; D013792:Thalidomide